Vaxart, Inc.·4

Jun 14, 4:17 PM ET

Yedid Robert A. 4

4 · Vaxart, Inc. · Filed Jun 14, 2021

Insider Transaction Report

Form 4
Period: 2021-06-11
Transactions
  • Sale

    Common Stock

    2021-06-11$8.61/sh10,000$86,1098,240 total
  • Exercise/Conversion

    Common Stock

    2021-06-11$0.31/sh+18,240$5,65418,240 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-06-1118,24036,480 total
    Exercise: $0.31Exp: 2029-11-17Common stock (18,240 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest annually over three years from the vesting commencement date of October 25, 2019, the date of the grantee's appointment as a director of Vaxart, Inc.

Documents

2 files